United Kingdom reports 25 new blood-clot cases after AstraZeneca vaccine shots

United Kingdom reports 25 new blood-clot cases after AstraZeneca vaccine shots

Britain has registered 25 new cases of rare blood clots possibly linked to AstraZeneca Covid-19 vaccine. UK’s cases come as an addition to the numbers that have caused some European countries to adopt precautionary measures.

On Thursday, the Medicines and Healthcare Products Regulatory Agency (MHRA) said in a statement that 25 new cases of rare blood clots allegedly linked to AstraZeneca Covid-19 vaccine were reported in the UK. The U.K. agency further added that these fresh reports lift the total number of cases to 30 as of March 24.

MHRA underscored that the benefits of the shot continue to outweigh the risks. The regulator informed that the 30 incidents were out of 18.1 million doses of AstraZeneca vaccine given by March 24. The agency has also disclosed five cases on March 18, out of 11 million shots.

Including the new reports, the rate of incidents with the AstraZeneca shot in Britain, is about 1 in 600,000.

Till now, the United Kingdom has one of the world’s fastest-moving vaccine programs. It has administered vaccine jabs to more than half of all adults by late March.  Apart from AstraZeneca, Britain is currently using Pfizer Inc. and BioNTech SE to inoculate UK citizens.

Few days back, the EU drugs regulator revealed that a link between the AstraZeneca vaccine and a rare type of blood clot is possible. It cited 62 cases of the condition. Germany saw 31 cases of the rare clots which occurred mostly in women.  Norway and Denmark extended suspensions on the use of the shot over concerns over its use. On Friday, Australia registered one case of clotting disorder. AstraZeneca’s vaccine, developed with the University of Oxford, is currently facing dwindling support in Europe. But still countries are relying on the shot to help them exit the pandemic.

An updated recommendation will be issued next week by safety committee of the European Medicines Agency.

So far, there were no reports of the same reactions from Pfizer Inc. and BioNTech SE in the UK.

 

Share This

COMMENTS

Wordpress (0)
Disqus (0 )